Want to see GB:AREC full AI Analyst Report?
Arecor Therapeutics PLC (AREC) Income Statement
Arecor Therapeutics PLC Income Statement
Last quarter (Q2 2026), Arecor Therapeutics PLC's total revenue was $194.00K, a decrease of 90.28% from the same quarter last year. In Q2, Arecor Therapeutics PLC's net income was $-2.98M. See Arecor Therapeutics PLC’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.71M | $ 5.05M | $ 4.57M | $ 2.40M | $ 1.16M | |
| $ 1.05M | $ 1.54M | $ 4.57M | $ 2.40M | $ 1.16M | |
| $ 5.72M | $ 12.24M | $ 13.75M | $ 12.91M | $ 7.13M | |
| Depreciation and Amortization | $ 215.00K | $ 446.00K | $ 496.00K | $ 341.00K | $ 171.00K |
| $ -4.45M | $ -10.15M | $ -8.39M | $ -10.06M | $ -6.27M | |
| $ -4.67M | $ -10.70M | $ -9.18M | $ -11.66M | $ -5.98M | |
| $ 5.66M | $ 79.00K | $ 274.00K | $ 88.00K | $ -506.00K | |
| $ 994.00K | $ -10.62M | $ -8.90M | $ -10.54M | $ -6.95M | |
| $ 664.00K | $ -10.24M | $ -8.55M | $ -9.26M | $ -6.17M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.02 | $ -0.31 | $ -0.28 | $ -0.32 | $ -0.27 |
| Diluted EPS | $ 0.02 | $ -0.31 | $ -0.28 | $ -0.32 | $ -0.27 |
| Weighted Average Shares Outstanding | 37.76M | 33.44M | 30.62M | 28.94M | 23.03M |
| Weighted Average Shares Outstanding (Diluted) | 39.44M | 33.44M | 30.62M | 28.94M | 23.03M |
Currency in GBP
